Candriam SCA’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93M Buy
9,870
+775
+9% +$216K 0.02% 462
2025
Q4
$1.76M Buy
9,095
+1,955
+27% +$335K 0.01% 519
2025
Q3
$983K Buy
7,140
+603
+9% +$65.9K 0.01% 578
2025
Q2
$588K Sell
6,537
-3,207
-33% -$256K ﹤0.01% 630
2025
Q1
$805K Buy
+9,744
New +$1.09M 0.01% 611
2023
Q2
Sell
-8,774
Closed -$868K 859
2023
Q1
$868K Sell
8,774
-5,846
-40% -$598K 0.01% 715
2022
Q4
$1.28M Sell
14,620
-3,784
-21% -$324K 0.01% 665
2022
Q3
$1.38M Buy
18,404
+11,529
+168% +$1.05M 0.01% 653
2022
Q2
$616K Hold
6,875
0.01% 702
2022
Q1
$813K Buy
6,875
+777
+13% +$98.4K 0.01% 690
2021
Q4
$997K Sell
6,098
-2,206
-27% -$310K 0.01% 659
2021
Q3
$907K Sell
8,304
-82
-1% -$9.96K 0.01% 723
2021
Q2
$1.12M Buy
+8,386
New +$1.07M 0.01% 699
2020
Q4
Sell
-4,313
Closed -$343K 847
2020
Q3
$343K Hold
4,313
﹤0.01% 734
2020
Q2
$365K Sell
4,313
-750
-15% -$50.3K ﹤0.01% 726
2020
Q1
$337K Hold
5,063
﹤0.01% 737
2019
Q4
$345K Sell
5,063
-48,228
-90% -$3.06M ﹤0.01% 755
2019
Q3
$3.09M Buy
+53,291
New +$2.82M 0.04% 410

Other funds holding TER

Candriam SCA's TER Position: Q1 2026 in Review

Candriam SCA increased its Teradyne (TER) stake by 8.5% in Q1 2026, buying an estimated $216K and bringing the position to 9,870 shares worth $2.93M. The position accounts for 0.02% of the portfolio, ranked #462.

Candriam SCA first reported a position in TER in Q3 2019 and has held it in 18 quarters since. The position peaked at $3.09M in Q3 2019. 1,223 funds tracked by Wall St. Rank hold TER as of Q1 2026.

  • Candriam SCA held 9,870 shares of Teradyne worth $2.93M as of Q1 2026.
  • Candriam SCA bought 775 Teradyne shares in Q1 2026, an estimated $216K.
  • Teradyne made up 0.02% of Candriam SCA's portfolio in Q1 2026, its #462 holding.
  • Candriam SCA first reported a position in Teradyne in Q3 2019 and has held it in 18 quarters since.
  • Candriam SCA's Teradyne position peaked at $3.09M in Q3 2019.
  • 1,223 funds tracked by Wall St. Rank held Teradyne as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.